Discovery - University of Dundee - Online Publications

Library & Learning Centre

Synthesis, chemical reactivity as Michael acceptors, and biological potency of monocyclic cyanoenones, novel and highly potent anti-inflammatory and cytoprotective agents

Synthesis, chemical reactivity as Michael acceptors, and biological potency of monocyclic cyanoenones, novel and highly potent anti-inflammatory and cytoprotective agents

Research output: Contribution to journalArticle

View graph of relations

Authors

  • Suqing Zheng
  • Y. R. Santosh Laxmi
  • Emilie David
  • Albena T. Dinkova-Kostova
  • Katherine H. Shiavoni
  • Yanqing Ren
  • Ying Zheng
  • Isaac Trevino
  • Ronald Bumeister
  • Iwao Ojima
  • W. Christian Wigley
  • James B. Bliska
  • Dale F. Mierke
  • Tadashi Honda

Research units

Info

Original languageEnglish
Pages4837-4846
Number of pages10
JournalJournal of Medicinal Chemistry
Journal publication date24 May 2012
Journal number10
Volume55
DOIs
StatePublished

Abstract

Novel monocyclic cyanoenones examined to date display unique features regarding chemical reactivity as Michael acceptors and biological potency. Remarkably, in some biological assays, the simple structure is more potent than pentacyclic triterpenoids (e.g., CDDO and bardoxolone methyl) and tricycles (e.g., TBE-31). Among monocyclic cyanoenones, 1 is a highly reactive Michael acceptor with thiol nucleophiles. Furthermore, an important feature of 1 is that its Michael addition is reversible. For the inhibition of NO production, 1 shows the highest potency. Notably, its potency is about three times higher than CDDO, whose methyl ester (bardoxolone methyl) is presently in phase III clinical trials. For the induction of NQO1, 1 also demonstrated the highest potency. These results suggest that the reactivity of these Michael acceptors is closely related to their biological potency. Interestingly, in LPS-stimulated macrophages, 1 causes apoptosis and inhibits secretion of TNF-alpha and IL-1 beta with potencies that are higher than those of bardoxolone methyl and TBE-31.</p>

Documents

Library & Learning Centre

Contact | Accessibility | Policy